Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate for Cachexia in Stage III Gastric/GEJ Cancer Receiving Neoadjuvant Serplulimab + SOX
NCT07391826Phase 2Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of megestrol in cachexia, sponsored by Jiangsu Provincial People's Hospital. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT07391826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391826.